HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

In this episode of HOPA Now, Brian Doe details the background and pathophysiology of lymphoma, how to differentiate T-cell lymphomas, and the aggressive nature of all the lymphomas. He highlights the characteristics and symptoms of various forms of lymphoma and makes recommendations for treatments based on pathological and cellular findings.

In this episode you will learn:

Lymphomas Fundamentals

• Lymphoma presentation and pathophysiology
• Hallmark signs and common symptoms of lymphoma
• Varying characteristics of Hodgkins and non-Hodgkin’s lymphomas
• Characteristics and risks of indolent lymphomas including follicular lymphoma, B-cell lymphoma, and mantle cell lymphoma
• T-cell lymphomas, symptoms, and the effect they have on organs
• Goals of therapy and the effects of peripheral T-cell lymphoma

Mentioned in This Episode:

HOPA

Quotes:

“Hodgkin’s lymphomas, in general, have good prognosis and are considered curable with standard chemotherapy such as ABVD.” — Brian Doe

“Non-Hodgkin’s lymphomas are more responsive to chemotherapy and may be curable despite its aggressive nature.” — Brian Doe

“Controversy exists in how grade 3 follicular lymphoma should be treated as it mimics a more aggressive disease course and carries a risk of transformation to diffuse large B-cell lymphoma.” — Brian Doe